Summary of American Thyroid Association recommendations for treatment of subclinical hyperthyroidism
| Thyroid-stimulating hormone persistently < 0.10 mIU/L | Thyroid-stimulating hormone between 0.10 mIU/L and lower limit of normal | |
|---|---|---|
| Any symptoms, age ≥ 65, cardiovascular disease, osteoporosis, postmenopausal and not on estrogen or osteoporosis treatment | Treatment is recommended | Consider treatment |
| None of the above | Consider treatment | Observation is recommended |
Based on information from reference 6.